Sister chromatid exchange and chromosome breakage in complete hydatidiform moles.
Women with complete hydatidiform moles (CHM) are at a 10% risk for developing persistent trophoblastic disease or choriocarcinoma. We studied sister chromatid exchange (SCE) as a prognostic indicator for malignancy in peripheral blood lymphocytes (PBL) from women with CHM and their husbands, but found no differences from normal control couples. SCE levels in cultured tissue derived from 11 CHM (avg. 7.9) and 2 choriocarcinomas (avg. 6.8) were not significantly different from those of 8 normal skin fibroblast cultures (avg. 7.8). These same tissues were then examined for chromosome breakage which was significantly higher for CHM (0.48/cell) and choriocarcinoma (0.87/cell) than normal fibroblasts (0.33/cell). Chromosome breaks occurred at 50-60% known fragile sites and at 50-55% of cancer breakpoints. Whereas SCE was only associated with 13% of breaks in the three tissues, half of these were at known fragile sites. Our results suggest that SCE is not an indicator of malignancy in PBL or cultured cells from CHM or choriocarcinoma and that the level of SCE is not elevated in CHM or choriocarcinoma. However, our results confirm the increased breakage seen in the latter two tissues which may represent general DNA instability predisposing to choriocarcinoma and its accompanying chromosomal rearrangements.
Becker
R A
RA
Department of Pediatrics, School of Medicine, University of Pittsburgh, Pennsylvania.
Surti
U
U
Wenger
S L
SL
D002478:Cells, Cultured; D002822:Choriocarcinoma / Q000235:genetics; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000235:genetics*; D011247:Pregnancy; D012854:Sister Chromatid Exchange; D014407:Tumor Cells, Cultured; D014594:Uterine Neoplasms / Q000235:genetics*